Necroptosis has been reported to drive systemic inflammatory response syndrome (SIRS) [131], while necroptosis inhibition by genetic means (e.g., deletion in RIPK3 gene) or by pharmacological means (RIPK1 inhibition by necrostatin-1) protects against SIRS [131]. This evidence concerns the gene RIPK3 and systemic inflammatory response syndrome.